RxDoctor Payments DataLook up a doctor →

Hemant Kalia, MD

Interventional Pain Medicine · Rochester, NYNPI 1689879959

Payments from drug & device makers

$234,498in general payments, 2019–2025

Across 532 payments — averaging $440.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$161K
  • Averitas Pharma Inc.$25K
  • Curonix LLC$12K
  • Saluda Medical Americas, Inc.$11K
  • Bioventus LLC$8K
  • Nalu Medical, Inc.$3K
  • plus $14K from 19 others
$820in research payments, 2019–2025

Across 1 payment — averaging $820.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$820

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$234,498 in reported general payments places this provider in the 95th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$62,526
Medicare patients
154
Services billed
672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →